Latest
New SPAC: Frazier Life Sciences Acquisition Corp. II (FLSC) Files for $75M IPO
Frazier Life Sciences II (NASDAQ:FLSC) has filed for a $75 million shares-only SPAC with a biotech focus and a particular interest in companies developing genetic and molecular cancer drug candidates. The offering is not handing out IPO investors other goodies in the form of overfunding and it will have a full 24 months to initially complete a business combination. More
Nicholas Alan Clayton·Sep 24
FLSC$75M
